Trial Profile
Molecular pathways associated with enzalutamide response in men with metastatic castration resistant prostate cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Jul 2014
Price :
$35
*
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Pharmacogenomic; Therapeutic Use
- 23 Jul 2014 New trial record